During the past decade, CHU Amiens Nord conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU Amiens Nord" are "Adhesion Prevention" (1 trials) and "Cervical Dystonia" (1 trials). Many other conditions were trialed in "CHU Amiens Nord" in a lesser frequency.

Most popular intervention types in "CHU Amiens Nord" are "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum toxin type A" (1 trials) and "Sepraspray" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Amiens Nord" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHU Amiens Nord". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CHU Amiens Nord, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Amiens Nord, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".